AffyImmune Announces Appointment of Daniel Janse, Ph.D. as President and CEO
Key Highlights Daniel Janse, Ph.D., appointed President and CEO of AffyImmune. Dr. Janse brings 20 years of biopharmaceutical…
Browsing Tag
Juno Therapeutics
1 post